Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | GPR119 | Q8TDV5 | 7/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 3/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21513390 | 0.91 | EPHX2 (0.47) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL2344292 | 0.88 | HPGD (0.47) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL2340756 | 0.88 | HPGD (0.47) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL3245456 | 0.86 | GPR119 (0.46) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL1474868 | 0.84 | USP2 (0.49) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL22305158 | 0.84 | USP2 (0.49) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL3239207 | 0.84 | GPR119 (0.44) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL29326315 | 0.83 | USP2 (0.47) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL623537 | 0.83 | GPR119 (0.50) | HPGDGPR119USP2SMN1; SMN2EPHX2 | |
| SCHEMBL29024806 | 0.83 | USP2 (0.47) | HPGDGPR119USP2SMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025103502-A1 | COMPOUNDS AND METHODS OF TREATING CANCERS | CULLGEN INC. (US) | 2025-05-22 | — | — | WO | disclosed |